This webinar is an AAOS member benefit: Members attend for free! 

Description

As value-based care continues to evolve, orthopaedic surgeons must understand the policy and payment models driving the adoption of digital health technologies. This webinar will examine emerging CMS initiatives—including ACCESS, TEAM, CARA, and CJR-X—and discuss how these programs are shaping care delivery, quality measurement, and technology integration across musculoskeletal care. Faculty will provide an overview of the current policy landscape, highlight anticipated trends, and discuss strategies for preparing practices to successfully navigate the future of value-based care. 

Learning Objectives

• Describe the goals and key components of emerging CMS value-based care models, including ACCESS, TEAM, CARA, and CJR-X.  
• Explain how evolving healthcare policy is influencing the adoption and integration of digital health technologies within orthopaedic practice.  
• Identify opportunities for orthopaedic practices to prepare for and adapt to future value-based care initiatives through strategic technology integration and workflow planning. 

Director

Christian Pean, MD

Faculty

Reyann Davis, MD, Kathryn Davidson, MD, Marc Gruner, MD 

The American Academy of Orthopaedic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

If you are unable to attend the live webinar, you may still register to be notified upon the availability of the recorded session. Access to the recording will be granted for a duration of 2 years.

This webinar is an AAOS member benefit - members join for free!
 

Description

Artificial intelligence and augmented and virtual reality technologies are rapidly reshaping orthopaedic surgery, from preoperative planning and intraoperative navigation to skills training and postoperative outcome prediction. This session will provide surgeons with a practical overview of current AI and AR/VR applications in orthopaedic practice, exploring how these tools are being integrated into clinical workflows, surgical education, and patient care. The presentation will also address the practical, ethical, and regulatory considerations surgeons must weigh as these technologies become more prevalent. Attendees will leave with a clearer understanding of where this technology stands today, where it is headed, and how to thoughtfully evaluate its role in their own practice.

Learning Objectives

1.    Describe current and emerging applications of artificial intelligence in orthopaedic surgery, including diagnostic imaging analysis, preoperative planning, and outcome prediction.
2.    Identify how augmented reality and virtual reality platforms are being used to enhance surgical training, intraoperative navigation, and patient education.
3.    Evaluate the practical, ethical, and medicolegal considerations associated with adopting AI and AR/VR technologies into clinical practice, including data privacy, algorithmic bias, and liability.
4.    Assess strategies for integrating these tools into a surgical practice while maintaining patient safety and quality of care.
 

Director

Eric Swart, MD, FAAOS

Faculty

Sean Tabaie, MD, MBA, FAAOS, David Neuman, MD, FAAOS

The American Academy of Orthopaedic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

If you are unable to attend the live webinar, you may still register to be notified upon the availability of the recorded session. Access to the recording will be granted for a duration of 2 years.

This webinar is an AAOS member benefit: Members attend for free! 

Description

Preoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes in Orthopaedic Surgery: A Scoping Review of Perioperative and Recovery Outcomes

Introduction:
The rapid expansion of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use for weight management and diabetes has raised perioperative questions, particularly regarding delayed gastric emptying and infection risk. Emerging real-world data suggest a more nuanced perioperative profile. This scoping review synthesizes evidence on preoperative GLP-1 RA exposure and postoperative outcomes across orthopaedic procedures, with emphasis on soft-tissue sports medicine, and is intended to map associative perioperative outcomes rather than establish causality.

Methods:
Following Arksey-O'Malley and Joanna Briggs Institute methodology and PRISMA-ScR reporting, we searched PubMed, Scopus, Web of Science, CINAHL Ultimate, Academic Search Premier, and Ovid Emcare (2015 to 2025). Eligible studies evaluated adult orthopaedic patients with documented GLP-1 RA use and postoperative outcomes. Three reviewers independently screened and extracted study characteristics, exposure timing, perioperative management, and outcomes.

Results:
Of 117 records screened, 35 studies met inclusion. Most were large retrospective cohorts spanning arthroplasty, spine fusion, trauma fixation, foot/ankle fusion, shoulder arthroplasty, and rotator cuff repair. Across hip, knee, and shoulder arthroplasty, GLP-1 RA use was generally associated with similar or lower 90-day complications, reduced periprosthetic joint infection, shorter length of stay, and fewer readmissions or revisions. Spine findings were mixed: Several cohorts showed lower infection and readmission, while others noted increased pneumonia, acute kidney injury, or pseudarthrosis in long-term semaglutide users. Trauma and ankle fracture cohorts showed no increase in short-term complications and in some cases lower mortality, with isolated signals for increased late fall-related injuries. Soft-tissue cohorts (rotator cuff repair and distal radius fixation) demonstrated fewer adverse events without increased aspiration or revision surgery risk. Functional outcomes (PROMIS) were rarely reported.

Conclusion:
Preoperative GLP-1 RA exposure is not broadly associated with increased postoperative risk and often correlates with lower infection, readmission, and mortality rates—particularly in arthroplasty, spine, and ankle fracture fixation cohorts. Findings in spine surgery are more mixed and warrant cautious interpretation, especially with prolonged semaglutide exposure. Outcomes in sports-medicine procedures seem reassuring, although prospective multicenter studies with standardized perioperative protocols and PROMIS-based outcomes are needed.

Learning Objectives

• Review the current evidence regarding preoperative GLP-1 receptor agonist use and its association with postoperative outcomes across common orthopaedic procedures.
• Evaluate the potential benefits and risks of perioperative GLP-1 receptor agonist use, including effects on infection rates, readmissions, complications, and recovery following orthopaedic surgery.
• Compare postoperative outcomes associated with GLP-1 receptor agonist use among arthroplasty, spine, trauma, foot and ankle, and sports medicine procedures, recognizing areas where evidence is consistent and where uncertainty remains.
• Apply current evidence to perioperative decision-making and patient counseling regarding GLP-1 receptor agonist management in orthopaedic surgical practice.

Director

Jonathan Grauer, MD, FAAOS

Co-Authors

Isabella Strickler, BA, Annabella Jensen, BS, Kyle Cragg, BS, Robert Dean, MD, Ryan McNassor, MD, Joe Guettler, MD, FAAOS, James Bicos, MD, FAAOS

The American Academy of Orthopaedic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

If you are unable to attend the live webinar, you may still register to be notified upon the availability of the recorded session. Access to the recording will be granted for a duration of 2 years.